US equities |
MU $1,067.13 ▼-1.92% NVDA $233.92 ▼-1.50% PLTR $200.83 ▲+3.45% SNDK $1,639.08 ▼-3.15% META $720.35 ▼-0.13% AMD $633.94 ▼-1.85% GOOGL $351.11 ▲+0.17% TSLA $372.26 ▼-1.47%
FinancialContent

Amphastar Pharmaceuticals, Inc. - Common Stock (NQ:AMPH)

25.30 -0.24 (-0.96%)
Delayed Quote Updated: 9:56 AM EDT, Oct 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Amphastar Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 Next >
News headline image
Amphastar Pharmaceuticals to Present at the 2026 Jefferies Healthcare Conference
Via ACCESS Newswire
News headline image
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2026
Via ACCESS Newswire
News headline image
Amphastar Pharmaceuticals to Present at the 2026 Bank of America Health Care Conference
Via ACCESS Newswire
News headline image
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7, 2026
Via ACCESS Newswire
News headline image
Amphastar Pharmaceuticals to Present at the 25th Annual Needham Healthcare Conference
Via ACCESS Newswire
News headline image
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2024
Via ACCESS Newswire
News headline image
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2025
Via ACCESS Newswire
News headline image
Amphastar Announces FDA Approval for Ipratropium Bromide HFA
Via ACCESS Newswire
News headline image
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 26, 2026
Via ACCESS Newswire
News headline image
Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound
Via ACCESS Newswire
News headline image
Amphastar Pharmaceuticals to Present at the J.P. Morgan 2026 Healthcare Conference
Via ACCESS Newswire
News headline image
Amphastar Announces FDA Approval for Teriparatide Injection
Via ACCESS Newswire
News headline image
Amphastar Pharmaceuticals to Present at the 37th Annual Piper Sandler Healthcare Conference
Via ACCESS Newswire
News headline image
Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
Via ACCESS Newswire
News headline image
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2025
Via ACCESS Newswire
News headline image
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6th, 2025
Via ACCESS Newswire
News headline image
Amphastar Pharmaceuticals to Present at the 2025 Wells Fargo Healthcare Conference
Via ACCESS Newswire
News headline image
Amphastar Pharmaceuticals Bolsters Proprietary Pipeline Through Exclusive Licensing Agreement with Nanjing Anji Biotechnology Co., Ltd.
Via ACCESS Newswire
News headline image
Amphastar Announces FDA Approval for Iron Sucrose Injection, USP
Via ACCESS Newswire
News headline image
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2025
Via ACCESS Newswire
News headline image
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7th, 2025
Via ACCESS Newswire
News headline image
Amphastar Pharmaceuticals Aims to Quadruple Domestic Manufacturing Capacity at Rancho Cucamonga Headquarters
Via ACCESS Newswire
News headline image
Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
Via ACCESS Newswire
News headline image
Amphastar Pharmaceuticals to Present at the 2025 Bank of America Health Care Conference
Via ACCESS Newswire
News headline image
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025
Via ACCESS Newswire
News headline image
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7th, 2025
Via ACCESS Newswire
News headline image
Amphastar Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference
Via ACCESS Newswire
News headline image
International Medication Systems, Ltd. Receives FDA's Drug Shortage Assistance Award
Via ACCESS Newswire
News headline image
Amphastar Pharmaceuticals to Present at the Barclays 27th Annual Global Healthcare Conference
Via ACCESS Newswire
News headline image
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 27, 2025
Via ACCESS Newswire
< Previous 1 2 3 4 Next >